Volterra Technologies’s Edwards Lifesciences EW Stock Holding History

Volterra Technologies’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,300	Closed	-$571K	–	424
2025 Q2	$571K	Buy	+7,300	New	+$544K	0.07%	260

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Volterra Technologies's EW Position: Q1 2026 in Review

Volterra Technologies sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 7,407 shares — an estimated $631K sold.

Volterra Technologies first reported a position in EW in Q4 2025 and held it in 1 quarter. The position peaked at $631K in Q4 2025. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Volterra Technologies reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
Volterra Technologies sold 7,407 Edwards Lifesciences shares in Q1 2026, an estimated $631K.
Volterra Technologies first reported a position in Edwards Lifesciences in Q4 2025 and held it in 1 quarter.
Volterra Technologies's Edwards Lifesciences position peaked at $631K in Q4 2025.
1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Volterra Technologies's 13F filing for Q1 2026, filed 14 May 2026.